REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,709,000 | +72.6% | 63,279 | +56.1% | 0.45% | +2.0% |
Q2 2020 | $990,000 | -39.2% | 40,541 | -63.1% | 0.44% | -53.3% |
Q1 2020 | $1,627,000 | -26.5% | 109,939 | -19.4% | 0.95% | +7.4% |
Q4 2019 | $2,214,000 | +60.1% | 136,443 | +203.9% | 0.89% | +23.6% |
Q1 2018 | $1,383,000 | -13.8% | 44,898 | 0.0% | 0.72% | -12.8% |
Q4 2017 | $1,605,000 | – | 44,898 | – | 0.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |